Irenic Capital Management LP

Position in QURE — uniQure N.V.

CIK 1929389 NEW YORK, NY

Position in QURE

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$1,635,000

New position

Shares Held

100,000

first reported quarter

Ownership

0.159%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Irenic Capital Management LP holds $60,349,374 across 6 Biotechnology names. QURE ranks #3 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TBPH	Theravance Biopharma, Inc.	2,760,948	$44,810,186
2	JANX	Janux Therapeutics, Inc.	765,804	$10,644,675
3	QURE	uniQure N.V. This page	100,000	$1,635,000
4	AVIR	Atea Pharmaceuticals, Inc.	301,699	$1,623,140
5	FATE	Fate Therapeutics Inc	878,055	$1,053,666
6	VOR	Vor Biopharma Inc.	32,663	$582,707

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,635,000	100,000	—	Shares	Sole	2026-05-18
No filing history on record for this holder in this stock.